Engineering the Next Generation of Drug Discovery, Cell & Gene Therapy Applications Designed with CRISPR experts from the likes of CRISPR Therapeutics, Astrazeneca, AbbVie, Broad Institute, Casebia, Merck, Amgen and academic key opinion leaders, this year’s meeting encapsulates the critical scientific challenges and opportunities of CRISPR applications. Tackling delivery, safety, precision and efficiency best practice, further optimize your drug discovery, functional screening and translation of CRISPR-based cell and gene therapy into the clinic. With the first wave of CRISPR based therapeutic clinical trials firmly underway, the 5th Precision CRISPR Genome Editing Congress is perfectly timed to demonstrate the growing applications of CRISPR and unique approaches to gene therapy.Time: 8:00 am - 5:00 pmVenue details: The Westin Boston Waterfront, 425 Summer Street, Boston, 02210, United States